Immunization against neonatal tetanus in New Guinea

Area of Science:

• Immunology
• Public Health
• Vaccinology

Background:

• Neonatal tetanus remains a significant public health concern.
• Previous studies have investigated tetanus toxoid immunization in women.
• Adjuvants play a crucial role in enhancing vaccine efficacy.

Purpose of the Study:

• To evaluate long-term tetanus antitoxin titres after primary immunization with different toxoids.
• To assess the impact of age, abscess formation, and pregnancy on antitoxin response.
• To compare the efficacy of plain versus aluminium phosphate (AlPO(4))-adsorbed toxoid boosters during pregnancy.

Main Methods:

• Longitudinal study of tetanus antitoxin titres in women post-immunization.
• Analysis of booster responses to plain and AlPO(4)-adsorbed toxoids.
• Investigation of factors influencing antitoxin response, including age and abscess formation.

Main Results:

• Aluminium adjuvant toxoid is recommended for neonatal tetanus prevention.
• Protective antitoxin levels were maintained for 40 months but not 54 months after two primary injections.
• Booster response was significantly higher with AlPO(4)-adsorbed toxoids compared to plain toxoids.
• Oil adjuvant toxoids (1 injection) provided similar persistence of protective levels as AlPO(4)-adsorbed toxoids (2 injections).
• Abscess formation was associated with higher antitoxin levels, while age had no significant effect.
• Pregnancy appeared to increase the response rate to adsorbed toxoids.

Conclusions:

• Aluminium adjuvant toxoids are effective for tetanus prevention, offering sustained protective antitoxin levels.
• AlPO(4)-adsorbed toxoids provide a superior booster response compared to plain toxoids.
• Further research is needed on antigen dose variations and responses in diverse populations.